JP2016529306A5 - - Google Patents

Download PDF

Info

Publication number
JP2016529306A5
JP2016529306A5 JP2016539571A JP2016539571A JP2016529306A5 JP 2016529306 A5 JP2016529306 A5 JP 2016529306A5 JP 2016539571 A JP2016539571 A JP 2016539571A JP 2016539571 A JP2016539571 A JP 2016539571A JP 2016529306 A5 JP2016529306 A5 JP 2016529306A5
Authority
JP
Japan
Prior art keywords
alkyl
cyano
hydroxyl
disease
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539571A
Other languages
English (en)
Japanese (ja)
Other versions
JP6408008B2 (ja
JP2016529306A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/069088 external-priority patent/WO2015032945A1/en
Publication of JP2016529306A publication Critical patent/JP2016529306A/ja
Publication of JP2016529306A5 publication Critical patent/JP2016529306A5/ja
Application granted granted Critical
Publication of JP6408008B2 publication Critical patent/JP6408008B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539571A 2013-09-09 2014-09-08 ジペプチジルペプチダーゼiインヒビターとしてのペプチジルニトリル化合物 Active JP6408008B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13183519.1 2013-09-09
EP13183519 2013-09-09
EP14151979.3 2014-01-21
EP14151979 2014-01-21
PCT/EP2014/069088 WO2015032945A1 (en) 2013-09-09 2014-09-08 Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors

Publications (3)

Publication Number Publication Date
JP2016529306A JP2016529306A (ja) 2016-09-23
JP2016529306A5 true JP2016529306A5 (enExample) 2017-10-12
JP6408008B2 JP6408008B2 (ja) 2018-10-17

Family

ID=51535425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016539571A Active JP6408008B2 (ja) 2013-09-09 2014-09-08 ジペプチジルペプチダーゼiインヒビターとしてのペプチジルニトリル化合物

Country Status (10)

Country Link
US (1) US9856228B2 (enExample)
EP (1) EP3044214B1 (enExample)
JP (1) JP6408008B2 (enExample)
CN (1) CN105612149A (enExample)
AU (1) AU2014317048B2 (enExample)
CA (1) CA2923484C (enExample)
DK (1) DK3044214T3 (enExample)
EA (1) EA029030B1 (enExample)
SG (1) SG11201601150WA (enExample)
WO (2) WO2015032943A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201601150WA (en) 2013-09-09 2016-03-30 Prozymex As Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors
NO2699580T3 (enExample) 2014-01-24 2018-02-24
DK3265452T3 (en) 2015-03-05 2020-06-08 Neuprozyme Therapeutics ApS Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors
CN107690429B (zh) * 2015-04-07 2022-02-25 Ela制药有限公司 用于治疗和/或预防细胞或组织坏死的组合物,其特异性靶向组织蛋白酶c和/或cela1和/或cela3a和/或与其结构相关的酶
PL3758708T3 (pl) 2018-03-01 2025-03-31 Astrazeneca Ab Kompozycje farmaceutyczne zawierające (2s)-{(1s)-1-cyjano-2-[4-(3-metylo-2-okso-2,3-dihydro-1,3-benzoksazol-5-ilo)fenylo]etylo}-1,4-oksazepano-2-karboksyamid
EP3823627A4 (en) 2018-07-17 2022-04-20 Insmed Incorporated CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR THE TREATMENT OF LUPUS ENEHROPATHY
JP2023535332A (ja) 2020-07-20 2023-08-17 インスメッド インコーポレイテッド 好中球セリンプロテアーゼを抽出するおよびジペプチジルペプチダーゼ1媒介性病態を治療するための方法
AU2023296161A1 (en) 2022-06-13 2025-01-02 Alivexis, Inc. Azacycloalkyl carbonyl cyclic amine compound
EP4646265A1 (en) 2023-01-06 2025-11-12 Insmed Incorporated Novel, reversible dpp1 inhibitors and uses thereof
WO2025162472A1 (en) * 2024-01-31 2025-08-07 Insmed Incorporated Linear dipeptidyl peptidase 1 inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0820665A2 (pt) * 2007-12-12 2018-05-29 Astrazeneca Ab compostos de peptidil nitrilas, processos para fabricação dos mesmos, composição farmacêutica, combinação e uso de ditos compostos
KR100903499B1 (ko) 2007-12-27 2009-06-18 엔에이치엔비즈니스플랫폼 주식회사 검색 의도 분류에 따른 광고 제공 방법 및 상기 방법을수행하기 위한 시스템
BRPI1015540A2 (pt) * 2009-05-07 2019-09-24 Astrazeneca Ab ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''
WO2010142985A1 (en) * 2009-06-10 2010-12-16 Astrazeneca Ab Substituted n-[1-cyano-2-(phenyl)ethyl]piperidin-2-ylcarboxmide compounds 761
WO2011154677A1 (en) 2010-06-09 2011-12-15 Astrazeneca Ab Substituted n-[1-cyano-2-(phenyl)ethyl] 1-aminocycloalk-1-ylcarboxamide compounds - 760
WO2012119941A1 (en) * 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors
WO2012130299A1 (en) 2011-03-30 2012-10-04 Prozymex A/S Peptidase inhibitors
US8999975B2 (en) 2011-09-19 2015-04-07 Boehringer Ingelheim International Gmbh Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
SG11201601150WA (en) 2013-09-09 2016-03-30 Prozymex As Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors

Similar Documents

Publication Publication Date Title
JP2016529306A5 (enExample)
JP2018507223A5 (enExample)
JP2018535967A5 (enExample)
JP2013537203A5 (enExample)
JP2013523802A5 (enExample)
JP2018534348A5 (enExample)
JP2017523225A5 (enExample)
JP2014097964A5 (enExample)
JP2010530897A5 (enExample)
JP2019524883A5 (enExample)
JP2014511891A5 (enExample)
JP2017530959A5 (enExample)
JP2018510139A5 (enExample)
JP2015508103A5 (enExample)
JP2016510326A5 (enExample)
JP2016525130A5 (enExample)
JP2016500111A5 (enExample)
JP2020532547A5 (enExample)
JP2015024998A5 (enExample)
JP2016540749A5 (enExample)
JP2014515351A5 (enExample)
JP2014528403A5 (enExample)
CN112368281A (zh) 作为pde3/pde4双重抑制剂的三并环类化合物
JP2019531279A5 (enExample)
JP2015508092A5 (enExample)